Full Press Release Details
The post May 26, 2026 3:30 PM EDT : TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA appeared first on Allogene .
ALLO Neutral Sentiment
May 26, 2026 3:30 PM EDT : TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
Key Takeaway: The article discusses the TD Cowen 7th Annual Oncology Innovation Summit, scheduled for May 26, 2026. It highlights the event's focus on insights related to the ASCO and EHA conferences. The post appears to be a brief announcement without detailed content or analysis.
Price reaction · baseline $2.045 (2026-05-26T13:40:00.000Z) · hit during market hours · 1 other ALLO headline(s) in the window, move may be shared
day 0 close · peak
+3.7%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
5.6%
average across 5 past catalysts
Cash runway
~39 mo
Minimal dilution risk
Lead asset
ALLO-715
Phase 1 · Relapsed/Refractory Multiple Myeloma